STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. Int. Res. J. Pharm. 2018;9(8):125-128. doi:10.56802/gzfvmr94